FOXR1 Human Pre-designed siRNA Set A contains three designed siRNAs for FOXR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FOXR2 Human Pre-designed siRNA Set A contains three designed siRNAs for FOXR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FOXRED1 Human Pre-designed siRNA Set A contains three designed siRNAs for FOXRED1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FOXRED2 Human Pre-designed siRNA Set A contains three designed siRNAs for FOXRED2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FOXS1 Human Pre-designed siRNA Set A contains three designed siRNAs for FOXS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FPGS Human Pre-designed siRNA Set A contains three designed siRNAs for FPGS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FPGT Human Pre-designed siRNA Set A contains three designed siRNAs for FPGT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FPR1 Human Pre-designed siRNA Set A contains three designed siRNAs for FPR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FPR2 Human Pre-designed siRNA Set A contains three designed siRNAs for FPR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FPR3 Human Pre-designed siRNA Set A contains three designed siRNAs for FPR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FR901379 (WF11899A) is a novel echinocandin-type lipopeptide antibiotic. FR901379 is primarily produced by mutant strain M-7 of Coleophoma empetri F-11899 (FERM BP-2635)[1].

FR900098 is an antimalarial agent that inhibits 1-deoxy-d-xylulose-5-phosphate (DXP) reductoisomerase. FR900098 has no significant acute toxicity or genotoxicity, and does not have the ability to cause chromosome breakage or heterogeneity. FR900098 has no effect on bone marrow red blood cells in NMRI mice[1].

FR900098 sodium is an antimalarial agent that inhibits 1-deoxy-d-xylulose-5-phosphate (DXP) reductoisomerase. FR900098 sodium has no significant acute toxicity or genotoxicity, and does not have the ability to cause chromosome breakage or heterogeneity. FR900098 sodium has no effect on bone marrow red blood cells in NMRI mice[1][2].

FRA10AC1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRA10AC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRAS1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRAS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRAT2 Human Pre-designed siRNA Set A contains three designed siRNAs for FRAT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FREM1 Human Pre-designed siRNA Set A contains three designed siRNAs for FREM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FREM2 Human Pre-designed siRNA Set A contains three designed siRNAs for FREM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FREM3 Human Pre-designed siRNA Set A contains three designed siRNAs for FREM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRG1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRG2 Human Pre-designed siRNA Set A contains three designed siRNAs for FRG2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRG2C Human Pre-designed siRNA Set A contains three designed siRNAs for FRG2C gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRK Human Pre-designed siRNA Set A contains three designed siRNAs for FRK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD3 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD4A Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD4A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD4B Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD4B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD5 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD6 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD7 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMD8 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMD8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMPD1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMPD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMPD2 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMPD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRMPD4 Human Pre-designed siRNA Set A contains three designed siRNAs for FRMPD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRRS1 Human Pre-designed siRNA Set A contains three designed siRNAs for FRRS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRRS1L Human Pre-designed siRNA Set A contains three designed siRNAs for FRRS1L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRS2 Human Pre-designed siRNA Set A contains three designed siRNAs for FRS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

FRS3 Human Pre-designed siRNA Set A contains three designed siRNAs for FRS3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Fructose-alanine-13C6 is 13C labeled Undeca-1,3,5-triene.

Fructose-glutamic acid-13C6 is 13C labeled 2-Ethyl-3,5-dimethylpyrazine,mixtureofisomers.